Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Finasteride - Polichem

Drug Profile

Finasteride - Polichem

Alternative Names: ALM-12845; Finjuve; P-3074

Latest Information Update: 05 Dec 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Polichem
  • Class Androstenes; Antiacnes; Antiandrogens; Antineoplastics; Azasteroids; Skin disorder therapies; Small molecules
  • Mechanism of Action Cholestenone 5 alpha-reductase inhibitors; Testosterone antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Alopecia

Most Recent Events

  • 05 Dec 2025 Finasteride is still Registered for Alopecia in Luxembourg
  • 16 Dec 2024 Launched for Alopecia in South Korea, Saudi Arabia, Portugal, Germany, Italy (Topical)
  • 16 Dec 2024 Registered for Alopecia in European Union (Topical)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top